MediciNova Inc logo

MediciNova Inc

$ 2.26 -0.02 (-0.88%) 10:01 AM EST
P/E:
At Loss
P/B:
1.45
Market Cap:
$ 110.84M
Enterprise V:
$ 42.85M
Volume:
17.44K
Avg Vol (2M):
27.51K
Also Trade In:
Volume:
17.44K
Market Cap $:
110.84M
PE Ratio:
At Loss
Avg Vol (2-Month):
27.51K
Enterprise Value $:
42.85M
PB Ratio:
1.45
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases. It has the acquisition and development of the small molecule therapeutics segments.
Name Current Vs Industry Vs History
Cash-To-Debt 354.53
Equity-to-Asset 0.94
Debt-to-EBITDA -0.01
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.6
Distress
Grey
Safe
Beneish M-Score -15.43
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 76.91
9-Day RSI 64.52
14-Day RSI 57.39
6-1 Month Momentum % -21.93
12-1 Month Momentum % -42.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.17
Quick Ratio 17.17
Cash Ratio 16.98
Days Sales Outstanding 38421.05

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.2

Financials (Next Earnings Date:2022-11-11 Est.)

MNOV's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:MNOV

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.038
EPS (TTM) ($) -0.26
Beta 0.51
Volatility % 28.12
14-Day RSI 57.39
14-Day ATR ($) 0.08816
20-Day SMA ($) 2.1905
12-1 Month Momentum % -42.78
52-Week Range ($) 2.08 - 4.65
Shares Outstanding (Mil) 49.05

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MediciNova Inc Filings

Document Form Filing Date
No Filing Data

MediciNova Inc Analysis

Share your research

Headlines

See More
No news.